Clinical Trials Directory

Trials / Completed

CompletedNCT04016025

A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers

Randomized Single-blind Study on the Adherence to Treatment With Topical Methylprednisolone Aceponate (Advantan®) in Different Vehicles (AD-HERE)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Jena University Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Untersuchung der Adhärenz zur topischen Standardtherapie bei Patienten mit chronischem Handekzem in Abhängigkeit von der Galenik

Detailed description

Prospective, randomized, parallel grouped, single-blinded (investigator), monocentric objective assessment of the adherence to the treatment with topical methylprednisolone aceponate (Advantan®) depending on the type of vehicle in patients with hand eczema treated according to the current Guideline.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAdherence to topical standard therapy assessedAdherence defined as percentage of patients applying at least aimed daily dose

Timeline

Start date
2020-12-02
Primary completion
2022-03-11
Completion
2022-04-14
First posted
2019-07-11
Last updated
2022-05-10

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04016025. Inclusion in this directory is not an endorsement.

A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers (NCT04016025) · Clinical Trials Directory